2376 - 2400 of 5898 Results
Title
Year
- Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression2021OPENTitle: Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00189-4Best OA location URL: https://www.nature.com/articles/s41531-021-00189-4.pdfCitation Count: 34
- Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning2021OPENTitle: Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learningJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-23311-9Best OA location URL: https://www.nature.com/articles/s41467-021-23311-9.pdfCitation Count: 204
- A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene2021OPENTitle: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 106Issue #:Start Page: 343.e1End Page: 343.e8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.05.010Citation Count: 6
- Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia2021OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 9
-
OPENTitle: Music to move persons with Parkinson’s disease: a personalized approachJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 1Start Page: 251End Page: 252Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10615-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10615-5.pdfCitation Count: 4
- Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease2021OPENTitle: Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01199-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01199-2Citation Count: 18
- Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?2021OPENTitle: Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1481End Page: 1482Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28673Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28673Citation Count: 4
-
OPENTitle: Machine Learning for Predicting Rare Clinical Outcomes—Finding Needles in a HaystackJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 5Start Page: e2110738End Page: e2110738Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.10738Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2780278/wang_2021_ic_210094_1620949822.15523.pdfCitation Count: 16
- The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers2021OPENTitle: The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their CarersJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1309End Page: 1323Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212611Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212611?id=journal-of-parkinsons-disease%2Fjpd212611Citation Count: 14
- Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology2021OPENTitle: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathologyJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 47Issue #: 7Start Page: 1080End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12728Best OA location URL: https://discovery.ucl.ac.uk/10127765/1/nan.12728.pdfCitation Count: 25
-
OPENTitle: Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1456End Page: 1460Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28616Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28616Citation Count: 5
-
OPENTitle: Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a SubgroupJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1468End Page: 1470Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28620Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A3638879/viewCitation Count: 1
- powerEQTL: an R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis2021OPENTitle: powerEQTL: an R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysisJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 37Issue #: 22Start Page: 4269End Page: 4271Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/bioinformatics/btab385Best OA location URL: https://doi.org/10.1093/bioinformatics/btab385Citation Count: 25
- α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease2021OPENTitle: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2508End Page: 2518Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28639Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28639Citation Count: 74
- Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy2021OPENTitle: Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid AngiopathyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.658605Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.658605/pdfCitation Count: 14
-
OPENTitle: Short hydrogen bonds enhance nonaromatic protein-related fluorescenceJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 21Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1073/pnas.2020389118Best OA location URL: https://doi.org/10.1073/pnas.2020389118Citation Count: 34
- Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells2021OPENTitle: Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cellsJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 147Issue #:Start Page: 105070End Page: 105070Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2021.105070Best OA location URL: https://discovery.ucl.ac.uk/10128142/1/1-s2.0-S0197018621001169-main.pdfCitation Count: 22
- Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study2021OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 22
- Restless Legs Syndrome Shows Increased Silent Postmortem Cerebral Microvascular Disease With Gliosis2021OPENTitle: Restless Legs Syndrome Shows Increased Silent Postmortem Cerebral Microvascular Disease With GliosisJournal Name: Journal of the American Heart AssociationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1161/jaha.120.019627Best OA location URL: https://www.ahajournals.org/doi/pdf/10.1161/JAHA.120.019627Citation Count: 14
-
OPENTitle: Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PDJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 12Start Page: 4759End Page: 4767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10586-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10586-7.pdfCitation Count: 8
- α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy2021OPENTitle: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02324-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02324-0.pdfCitation Count: 118
- DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease2021OPENTitle: DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1061End Page: 1074Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13239Best OA location URL: https://doi.org/10.1002/mdc3.13239Citation Count: 31
- Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode Network2021OPENTitle: Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode NetworkJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 31Issue #: 11Start Page: 5139End Page: 5150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/cercor/bhab148Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491681Citation Count: 24
- Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics2021OPENTitle: Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion TherapeuticsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 9Start Page: 4280End Page: 4292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-021-02418-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-021-02418-6.pdfCitation Count: 15
- Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's Disease2021OPENTitle: Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1979End Page: 1983Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28641Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/169296/2/mds28641_am.pdfCitation Count: 3